MiR-101 Is Involved in Human Breast Carcinogenesis by Targeting Stathmin1

Background MicroRNA-101 (miR-101) expression is negatively associated with tumor growth and blood vessel formation in several solid epithelial cancers. However, the role of miR-101 in human breast cancer remains elusive. Results MiR-101 was significantly decreased in different subtypes of human breast cancer tissues compared with that in adjacent normal breast tissues (P<0.01). Up-regulation of miR-101 inhibited cell proliferation, migration and invasion, and promoted cell apoptosis in ER alpha-positive and ER alpha-negative breast cancer cells and normal breast cells. Down-regulation of miR-101 displayed opposite effects on cell growth and metastasis. Further investigation revealed a significant inverse correlation between the expression of miR-101 and Stathmin1 (Stmn1), and miR-101 could bind to the 3′-untranslated region (UTR) of Stmn1 to inhibit Stmn1 translation. The inhibition of cell growth and metastasis induced by up-regulation of miR-101 was partially restored by overexpresson of Stmn1. Knockdown of Stmn1 attenuates the down-regulation of miR-101-mediated enhancement of cell growth and metastasis. More importantly, in vivo analysis found that Stmn1 mRNA and protein level in different subtypes of human breast cancer tissues, contrary to the down-regulation of miR-101, were significantly elevated. Conclusions This study demonstrates that down-regulation of miR-101 in different subtypes of human breast cancer tissues is linked to the increase of cellular proliferation and invasiveness via targeting Stmn1, which highlights novel regulatory mechanism in breast cancer and may provide valuable clues for the future clinical diagnosis of breast cancer.

[1]  Sofie Nilsson,et al.  Downregulation of miR-92a Is Associated with Aggressive Breast Cancer Features and Increased Tumour Macrophage Infiltration , 2012, PloS one.

[2]  Hongjiang Wang,et al.  Circulating MiR-125b as a Marker Predicting Chemoresistance in Breast Cancer , 2012, PloS one.

[3]  Isaac Crespo,et al.  A Novel Network Integrating a miRNA-203/SNAI1 Feedback Loop which Regulates Epithelial to Mesenchymal Transition , 2012, PloS one.

[4]  Jun Yu,et al.  Stathmin1 Plays Oncogenic Role and Is a Target of MicroRNA-223 in Gastric Cancer , 2012, PloS one.

[5]  Alfredo Hidalgo-Miranda,et al.  Identification and Pathway Analysis of microRNAs with No Previous Involvement in Breast Cancer , 2012, PloS one.

[6]  Xu Ma,et al.  MicroRNA‐181b and microRNA‐9 mediate arsenic‐induced angiogenesis via NRP1 , 2012, Journal of cellular physiology.

[7]  Päivi Heikkilä,et al.  MiR-34a Expression Has an Effect for Lower Risk of Metastasis and Associates with Expression Patterns Predicting Clinical Outcome in Breast Cancer , 2011, PloS one.

[8]  R. Batchu,et al.  MicroRNA-101 Inhibits Growth of Epithelial Ovarian Cancer by Relieving Chromatin-Mediated Transcriptional Repression of p21waf1/cip1 , 2011, Pharmaceutical Research.

[9]  Ying Xu,et al.  MicroRNA Expression and Regulation in Human Ovarian Carcinoma Cells by Luteinizing Hormone , 2011, PloS one.

[10]  C. Sotiriou,et al.  Global MicroRNA Expression Profiling Identifies MiR-210 Associated with Tumor Proliferation, Invasion and Poor Clinical Outcome in Breast Cancer , 2011, PloS one.

[11]  Donglei Liu,et al.  MicroRNA-101 Exerts Tumor-Suppressive Functions in Non-small Cell Lung Cancer through Directly Targeting Enhancer of Zeste Homolog 2 , 2011, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[12]  B. Tannous,et al.  miR-101 is down-regulated in glioblastoma resulting in EZH2-induced proliferation, migration, and angiogenesis , 2010, Oncotarget.

[13]  H. Ruan,et al.  MicroRNA-101 is down-regulated in gastric cancer and involved in cell migration and invasion. , 2010, European journal of cancer.

[14]  J. Olson,et al.  Targeting DNA-PKcs and ATM with miR-101 Sensitizes Tumors to Radiation , 2010, PloS one.

[15]  S. Hsieh,et al.  Stathmin1 overexpression associated with polyploidy, tumor‐cell invasion, early recurrence, and poor prognosis in human hepatoma , 2010, Molecular carcinogenesis.

[16]  A. Lal,et al.  MicroRNAs and their target gene networks in breast cancer , 2010, Breast Cancer Research.

[17]  J. Lieberman,et al.  miR-200 Enhances Mouse Breast Cancer Cell Colonization to Form Distant Metastases , 2009, PloS one.

[18]  E. Spisni,et al.  MiR-101 downregulation is involved in cyclooxygenase-2 overexpression in human colon cancer cells. , 2009, Experimental cell research.

[19]  Jian-Rong Yang,et al.  MicroRNA-101, down-regulated in hepatocellular carcinoma, promotes apoptosis and suppresses tumorigenicity. , 2009, Cancer research.

[20]  K. Imakawa,et al.  A microRNA, miR-101a, controls mammary gland development by regulating cyclooxygenase-2 expression. , 2009, Differentiation; research in biological diversity.

[21]  D. Bartel.  MicroRNAs: Target Recognition and Regulatory Functions , 2009, Cell.

[22]  S. Varambally,et al.  Genomic Loss of microRNA-101 Leads to Overexpression of Histone Methyltransferase EZH2 in Cancer , 2008, Science.

[23]  N. Rajewsky,et al.  Widespread changes in protein synthesis induced by microRNAs , 2008, Nature.

[24]  D. Bartel,et al.  The impact of microRNAs on protein output , 2008, Nature.

[25]  Shushan Rana,et al.  Stathmin 1: a novel therapeutic target for anticancer activity , 2008, Expert review of anticancer therapy.

[26]  P. Schirmacher,et al.  Protumorigenic overexpression of stathmin/Op18 by gain‐of‐function mutation in p53 in human hepatocarcinogenesis , 2007, Hepatology.

[27]  Yong Zhao,et al.  A developmental view of microRNA function. , 2007, Trends in biochemical sciences.

[28]  Y. Miki,et al.  Functional pathway characterized by gene expression analysis of supraclavicular lymph node metastasis-positive breast cancer , 2007, Journal of Human Genetics.

[29]  G. Atweh,et al.  Therapeutic interactions between stathmin inhibition and chemotherapeutic agents in prostate cancer , 2006, Molecular Cancer Therapeutics.

[30]  C. Burge,et al.  Conserved Seed Pairing, Often Flanked by Adenosines, Indicates that Thousands of Human Genes are MicroRNA Targets , 2005, Cell.

[31]  G. Atweh,et al.  Stathmin Inhibition Enhances Okadaic Acid-induced Mitotic Arrest , 2001, The Journal of Biological Chemistry.

[32]  G. Brattsand.  Correlation of oncoprotein 18/stathmin expression in human breast cancer with established prognostic factors , 2000, British Journal of Cancer.

[33]  V. Ambros,et al.  The lin-4 regulatory RNA controls developmental timing in Caenorhabditis elegans by blocking LIN-14 protein synthesis after the initiation of translation. , 1999, Developmental biology.

[34]  I. Bièche,et al.  Overexpression of stathmin in breast carcinomas points out to highly proliferative tumours , 1999, British Journal of Cancer.

[35]  I. Bièche,et al.  Overexpression of the stathmin gene in a subset of human breast cancer. , 1998, British Journal of Cancer.

[36]  G. Atweh,et al.  Role for protein phosphatases in the cell-cycle-regulated phosphorylation of stathmin. , 1998, The Biochemical journal.